{
  "id": "cdai_crohns",
  "title": "Crohn's Disease Activity Index (CDAI)",
  "description": "Quantifies disease activity in Crohn's disease patients using clinical symptoms and laboratory findings over a 7-day period",
  "category": "gastroenterology",
  "version": "1976",
  "parameters": [
    {
      "name": "liquid_stools_week",
      "type": "integer",
      "required": true,
      "description": "Total number of liquid or loose stools over the past 7 days (patient diary)",
      "validation": {
        "min": 0,
        "max": 200
      },
      "unit": "count"
    },
    {
      "name": "abdominal_pain_score",
      "type": "string",
      "required": true,
      "description": "Average daily abdominal pain rating over the past 7 days (0=none, 1=mild, 2=moderate, 3=severe)",
      "options": ["none", "mild", "moderate", "severe"],
      "validation": {
        "enum": ["none", "mild", "moderate", "severe"]
      },
      "unit": "score"
    },
    {
      "name": "general_wellbeing_score",
      "type": "string",
      "required": true,
      "description": "Average daily general well-being rating over the past 7 days (0=generally well, 1=slightly under par, 2=poor, 3=very poor, 4=terrible)",
      "options": ["generally_well", "slightly_under_par", "poor", "very_poor", "terrible"],
      "validation": {
        "enum": ["generally_well", "slightly_under_par", "poor", "very_poor", "terrible"]
      },
      "unit": "score"
    },
    {
      "name": "arthritis_arthralgias",
      "type": "string",
      "required": true,
      "description": "Presence of arthritis or arthralgias (joint pain/inflammation)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "presence"
    },
    {
      "name": "iritis_uveitis",
      "type": "string",
      "required": true,
      "description": "Presence of iritis or uveitis (eye inflammation)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "presence"
    },
    {
      "name": "erythema_nodosum",
      "type": "string",
      "required": true,
      "description": "Presence of erythema nodosum (skin inflammation)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "presence"
    },
    {
      "name": "anal_fissure_fistula",
      "type": "string",
      "required": true,
      "description": "Presence of anal fissure, fistula, or abscess",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "presence"
    },
    {
      "name": "other_fistulas",
      "type": "string",
      "required": true,
      "description": "Presence of other fistulas (excluding anal)",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "presence"
    },
    {
      "name": "fever",
      "type": "string",
      "required": true,
      "description": "Fever >37.8°C (100°F) during the past 7 days",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "presence"
    },
    {
      "name": "antidiarrheal_use",
      "type": "string",
      "required": true,
      "description": "Use of antidiarrheal medications (loperamide, diphenoxylate) during the past 7 days",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      },
      "unit": "presence"
    },
    {
      "name": "abdominal_mass",
      "type": "string",
      "required": true,
      "description": "Presence of abdominal mass on physical examination (0=none, 2=questionable, 5=definite)",
      "options": ["none", "questionable", "definite"],
      "validation": {
        "enum": ["none", "questionable", "definite"]
      },
      "unit": "presence"
    },
    {
      "name": "patient_sex",
      "type": "string",
      "required": true,
      "description": "Patient biological sex (for expected hematocrit calculation)",
      "options": ["male", "female"],
      "validation": {
        "enum": ["male", "female"]
      },
      "unit": "sex"
    },
    {
      "name": "observed_hematocrit",
      "type": "float",
      "required": true,
      "description": "Current hematocrit percentage (laboratory value)",
      "validation": {
        "min": 10.0,
        "max": 60.0
      },
      "unit": "percentage"
    },
    {
      "name": "current_weight",
      "type": "float",
      "required": true,
      "description": "Current body weight in kilograms",
      "validation": {
        "min": 30.0,
        "max": 300.0
      },
      "unit": "kg"
    },
    {
      "name": "ideal_weight",
      "type": "float",
      "required": true,
      "description": "Ideal body weight in kilograms (calculated or estimated)",
      "validation": {
        "min": 30.0,
        "max": 300.0
      },
      "unit": "kg"
    }
  ],
  "result": {
    "name": "cdai_score",
    "type": "integer",
    "unit": "points",
    "description": "Total CDAI score ranging from 0 to approximately 600 points"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 149,
        "stage": "Remission",
        "description": "Clinical remission",
        "interpretation": "CDAI <150 indicates clinical remission. Patients in this range are typically rated as 'very well' by physicians. Continue current maintenance therapy and monitor regularly."
      },
      {
        "min": 150,
        "max": 219,
        "stage": "Mild Disease",
        "description": "Mild disease activity",
        "interpretation": "CDAI 150-219 indicates mild disease activity. Consider optimization of current therapy or step-up treatment. Monitor closely and reassess in 2-4 weeks."
      },
      {
        "min": 220,
        "max": 299,
        "stage": "Moderate Disease",
        "description": "Moderate disease activity",
        "interpretation": "CDAI 220-299 indicates moderate disease activity. Consider corticosteroids, immunomodulators, or biologic therapy. Reassess in 2-4 weeks."
      },
      {
        "min": 300,
        "max": 450,
        "stage": "Severe Disease",
        "description": "Severe disease activity",
        "interpretation": "CDAI 300-450 indicates severe disease activity. Consider hospitalization, corticosteroids, immunosuppressants, or biologic therapy. Close monitoring required."
      },
      {
        "min": 451,
        "max": 600,
        "stage": "Very Severe Disease",
        "description": "Very severe disease activity",
        "interpretation": "CDAI >450 indicates very severe disease activity. Consider hospitalization, intensive medical therapy, or surgical intervention. Immediate specialist consultation recommended."
      }
    ]
  },
  "references": [
    "Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70(3):439-444.",
    "Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002;122(2):512-530.",
    "Jørgensen LG, Fredholm L, Hyltoft Petersen P, et al. How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)? Clin Chem Lab Med. 2005;43(4):403-411."
  ],
  "formula": "CDAI = (Liquid stools × 2) + (Abdominal pain × 5) + (General well-being × 7) + (Extraintestinal complications × 20) + (Antidiarrheal use × 30) + (Abdominal mass × 10) + (Hematocrit deficit × 6) + (Weight deficit × 1)",
  "notes": [
    "Requires 7-day patient diary for stool frequency, pain, and well-being scores",
    "Developed in 1976 by the National Cooperative Crohn's Disease Study Group",
    "Gold standard for assessing Crohn's disease activity in clinical trials",
    "A decrease of ≥70 points is considered a significant response to treatment",
    "A decrease of ≥100 points indicates a major clinical response",
    "Does not include endoscopic findings or quality of life measures",
    "Expected hematocrit: 47% for men, 42% for women",
    "Weight deficit calculated as percentage below ideal weight",
    "Should be used in conjunction with clinical judgment and other assessments"
  ]
}